Skip to content

Dr. Nina Karia

Active
Private limited companyfounded 2022active for 4 yearsHarmoniestraat 49, 2018 Antwerpen, BelgiumKBO/BCE: BE 0791.870.485

From the official registers: KBO 3 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. Nina Karia has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €134,496 and a net result of €16,776. Equity has been growing by about 26% per year since 2023. Its solvency ranks better than 92% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 04-10-2022 Normal situation
Legal form
Private limited company
Registered office
Harmoniestraat 49, 2018 Antwerpen
Activity
General medical practice NACE 86210
Establishment unit
2.336.512.244 2018 Antwerpen, since 04-10-2022
Financial year end
31 December
Peppol
Reachable since 21-07-2025

Board and ownership

Board

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€22,269
▼ 64.9%
Turnover
≈ €140,000
estimated
Profit
€16,776
▼ 63.2%
Equity
€134,496
▲ 14.3%
Total assets
€141,015
▲ 0.9%
2025 accounts filed 20 days after the deadline
Filed on 20-08-2026at the National Bank
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 35.56, cash €131,471Equity €134,496 (95.4% of total assets)Size: total assets €141,015Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 67% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 95.4% of total assets
Liquidity 100+2
short-term debt 2.8% · cash 93.2%
Profitability 84-16
return on assets 11.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025highest value 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €12,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 35.56 (7.67 in 2024), above the usual 1.5. Short-term debt is 2.8% and cash 93.2% of total assets. 4.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 33% on profitability and 58% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 35.56, cash €131,471
NBB · annual accounts
lowers risk · Equity €134,496 (95.4% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €141,015
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · 2025 accounts filed 20 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-08-2026, 20 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 3 filings
Deviation from the deadline
2025
20 days late
2024
28 days late
2023
6 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 18 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 August (3 of the last 3 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2022.
KBO publications

Key points

  • Positive: Higher solvency than 92% of companies in human healthsector median 63.0% · 20,678 companies 95.4% View

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Dr. Nina Karia

What is the company number of Dr. Nina Karia?
The company number of Dr. Nina Karia is 0791.870.485. The VAT number is the same number with BE in front: BE 0791.870.485.
Where is Dr. Nina Karia based?
The registered office is at Harmoniestraat 49, 2018 Antwerpen.Company details
What does Dr. Nina Karia do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Nina Karia?
The legal form of Dr. Nina Karia is Private limited company (BV).
When was Dr. Nina Karia founded?
Dr. Nina Karia was founded on 04-10-2022.
Is Dr. Nina Karia still active?
Yes, Dr. Nina Karia is an active enterprise in the KBO register.
What is the turnover of Dr. Nina Karia?
The turnover in financial year 2025 is ≈ €140,000. This figure is estimated from the gross margin of €22,269 and 48 comparable companies (NACE 86). It probably lies between €100,000 and €240,000. It is a rough estimate.Financials
Is Dr. Nina Karia profitable?
In financial year 2025, Dr. Nina Karia made a profit of €16,776.
Where can I find the annual accounts of Dr. Nina Karia?
Dr. Nina Karia filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Dr. Nina Karia due?
Dr. Nina Karia must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as Dr. Nina Karia: general medical practice (NACE 86210). They are comparable in size and age: total assets between €112,000 and €219,000, founded between 2021 and 2022.

CompanyTotal assetsGross margin
Dr. Nina Karia Antwerpen€141,015€22,269
Dr. Emmeline Deloddere - Huisarts Zwalm€151,246€25,051
Médisirona Limbourg€138,274€20,499
Docteur Charlotte Jacmin Soignies€188,625€22,171
Dokter Brenda Neirinckx Hamont-Achel€126,194€27,811
Apro-Med Mons€112,295€21,769
EVRE Antwerpen€218,793€25,713
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.